tirzepatide 12.5 mg Zepbound mg/0.5 mL injection (single-dose pen) Images GIP also stimulates insulin production and release from the pancreas Tirzepatide Dosage Chart: Weekly Dosing
Description
doi: 10.3389/fmed.2021.792846
In the SURMOUNT-1 obesity trial, participants lost an average of 15% to 21% of their body weight over 72 weeks
Metabolism 96, 4655
Missing are direct head-to-head studies comparing the two drugs
Weight regain after stopping semaglutide affects most patients, with studies showing average weight recovery of 50-70% within one year of discontinuation
-1775582446327.png&w=3840&q=75)
Transplantation is complicated in patients with Eisenmenger syndrome due to the multi-organ system dysfunction that is often present
